RenaMed Biologics
Westborough, Massachusetts, United States
About RenaMed Biologics
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizes physiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $40.0M
- Last round: Series Unknown (Sep 2006)
- Phone: +1 508-983-6420
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/renamed-biologics-2475432 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.